|
Volumn 358, Issue 13, 2008, Pages 1408-1409
|
An adult with type 2 citrullinemia presenting in Europe
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMMONIA;
CARRIER PROTEIN;
PROTEIN SLC25A13;
UNCLASSIFIED DRUG;
ASPARTIC ACID;
GLUTAMIC ACID;
MITOCHONDRIAL PROTEIN;
SLC25A13 PROTEIN, HUMAN;
ADULT;
AMINO ACID SUBSTITUTION;
AMMONIA BLOOD LEVEL;
BRAIN DISEASE;
CASE REPORT;
CITRULLINEMIA;
CITRULLINEMIA TYPE 2;
CLINICAL FEATURE;
EUROPE;
GENE SEQUENCE;
GENETIC SCREENING;
HETEROZYGOSITY;
HOMOZYGOSITY;
HUMAN;
HYPERAMMONEMIA;
HYPERAMMONEMIC ENCEPHALOPATHY;
LABORATORY TEST;
LETTER;
MALE;
POINT MUTATION;
PRIORITY JOURNAL;
ACTIVE TRANSPORT;
DNA SEQUENCE;
FATALITY;
GENETICS;
LIVER;
METABOLISM;
ADULT;
ASPARTIC ACID;
BIOLOGICAL TRANSPORT, ACTIVE;
CITRULLINEMIA;
EUROPE;
FATAL OUTCOME;
GLUTAMIC ACID;
HUMANS;
HYPERAMMONEMIA;
LIVER;
MALE;
MEMBRANE TRANSPORT PROTEINS;
MITOCHONDRIAL PROTEINS;
POINT MUTATION;
SEQUENCE ANALYSIS, DNA;
|
EID: 41449109046
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc0707353 Document Type: Letter |
Times cited : (26)
|
References (5)
|